Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

Kristin L White; Robert A Vierkant; Zachary C Fogarty; Bridget Charbonneau; Matthew S Block; Paul D P Pharoah; Georgia Chenevix-Trench; Mary Anne Rossing; Daniel W Cramer; Celeste Leigh Pearce; Joellen M Schildkraut; Usha Menon; Susanne Kruger Kjaer; Douglas A Levine; Jacek Gronwald; Hoda Anton Culver; Alice S Whittemore; Beth Y Karlan; Diether Lambrechts; Nicolas Wentzensen; Jolanta Kupryjanczyk; Jenny Chang-Claude; Elisa V Bandera; Estrid Hogdall; Florian Heitz; Stanley B Kaye; Peter A Fasching; Ian Campbell; Marc T Goodman; Tanja Pejovic; Yukie Bean; Galina Lurie; Diana Eccles; Alexander Hein; Matthias W Beckmann; Arif B Ekici; James Paul; Robert James (Jim) Brown; James M Flanagan; Philipp Harter; Andreas du Bois; Ira Schwaab; Claus K Hogdall; Lene Lundvall; Sara H Olson; Irene Orlow; Lisa E Paddock; Anja Rudolph; Ursula Eilber; Allan Jensen; for AOCS/ACS group;

doi:10.1158/1055-9965.EPI-13-0028

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

Kristin L White, Robert A Vierkant, Zachary C Fogarty, Bridget Charbonneau, Matthew S Block, Paul D P Pharoah, Georgia Chenevix-Trench, Mary Anne Rossing, Daniel W Cramer, Celeste Leigh Pearce, Joellen M Schildkraut, Usha Menon, Susanne Kruger Kjaer, Douglas A Levine, Jacek Gronwald, Hoda Anton Culver, Alice S Whittemore, Beth Y Karlan, Diether Lambrechts, Nicolas WentzensenJolanta Kupryjanczyk, Jenny Chang-Claude, Elisa V Bandera, Estrid Hogdall, Florian Heitz, Stanley B Kaye, Peter A Fasching, Ian Campbell, Marc T Goodman, Tanja Pejovic, Yukie Bean, Galina Lurie, Diana Eccles, Alexander Hein, Matthias W Beckmann, Arif B Ekici, James Paul, Robert James (Jim) Brown, James M Flanagan, Philipp Harter, Andreas du Bois, Ira Schwaab, Claus K Hogdall, Lene Lundvall, Sara H Olson, Irene Orlow, Lisa E Paddock, Anja Rudolph, Ursula Eilber, Allan Jensen, for AOCS/ACS group;

Patologi

19 Citationer (Scopus)

Abstract

Ovarian cancer is a leading cause of cancer-related death among women. In an effort to understand contributors to disease outcome, we evaluated single-nucleotide polymorphisms (SNP) previously associated with ovarian cancer recurrence or survival, specifically in angiogenesis, inflammation, mitosis, and drug disposition genes.

Originalsprog	Engelsk
Tidsskrift	Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Vol/bind	22
Udgave nummer	5
Sider (fra-til)	987-92
Antal sider	6
ISSN	1055-9965
DOI	https://doi.org/10.1158/1055-9965.EPI-13-0028
Status	Udgivet - maj 2013

Adgang til dokumentet

10.1158/1055-9965.EPI-13-0028

http://cebp.aacrjournals.org/content/22/5/987.full.pdf+html

Citationsformater

White, K. L., Vierkant, R. A., Fogarty, Z. C., Charbonneau, B., Block, M. S., Pharoah, P. D. P., Chenevix-Trench, G., Rossing, M. A., Cramer, D. W., Pearce, C. L., Schildkraut, J. M., Menon, U., Kjaer, S. K., Levine, D. A., Gronwald, J., Culver, H. A., Whittemore, A. S., Karlan, B. Y., Lambrechts, D., ... for AOCS/ACS group; (2013). Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 22(5), 987-92. https://doi.org/10.1158/1055-9965.EPI-13-0028

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. / White, Kristin L; Vierkant, Robert A; Fogarty, Zachary C et al.
I: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Bind 22, Nr. 5, 05.2013, s. 987-92.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

White, KL, Vierkant, RA, Fogarty, ZC, Charbonneau, B, Block, MS, Pharoah, PDP, Chenevix-Trench, G, Rossing, MA, Cramer, DW, Pearce, CL, Schildkraut, JM, Menon, U, Kjaer, SK, Levine, DA, Gronwald, J, Culver, HA, Whittemore, AS, Karlan, BY, Lambrechts, D, Wentzensen, N, Kupryjanczyk, J, Chang-Claude, J, Bandera, EV, Hogdall, E, Heitz, F, Kaye, SB, Fasching, PA, Campbell, I, Goodman, MT, Pejovic, T, Bean, Y, Lurie, G, Eccles, D, Hein, A, Beckmann, MW, Ekici, AB, Paul, J, Brown, RJ, Flanagan, JM, Harter, P, du Bois, A, Schwaab, I, Hogdall, CK, Lundvall, L, Olson, SH, Orlow, I, Paddock, LE, Rudolph, A, Eilber, U, Jensen, A & for AOCS/ACS group; 2013, 'Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome', Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, bind 22, nr. 5, s. 987-92. https://doi.org/10.1158/1055-9965.EPI-13-0028

White KL, Vierkant RA, Fogarty ZC, Charbonneau B, Block MS, Pharoah PDP et al. Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2013 maj;22(5):987-92. doi: 10.1158/1055-9965.EPI-13-0028

White, Kristin L ; Vierkant, Robert A ; Fogarty, Zachary C et al. / Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. I: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2013 ; Bind 22, Nr. 5. s. 987-92.

@article{12c4a051adf7483ab81ed2daa7145fa4,

title = "Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome",

abstract = "Ovarian cancer is a leading cause of cancer-related death among women. In an effort to understand contributors to disease outcome, we evaluated single-nucleotide polymorphisms (SNP) previously associated with ovarian cancer recurrence or survival, specifically in angiogenesis, inflammation, mitosis, and drug disposition genes.",

keywords = "Female, Genetic Association Studies, Genetic Predisposition to Disease, Genotype, Humans, Ovarian Neoplasms, Polymorphism, Genetic, Polymorphism, Single Nucleotide, Prognosis, Proportional Hazards Models, Survival Analysis",

author = "White, {Kristin L} and Vierkant, {Robert A} and Fogarty, {Zachary C} and Bridget Charbonneau and Block, {Matthew S} and Pharoah, {Paul D P} and Georgia Chenevix-Trench and Rossing, {Mary Anne} and Cramer, {Daniel W} and Pearce, {Celeste Leigh} and Schildkraut, {Joellen M} and Usha Menon and Kjaer, {Susanne Kruger} and Levine, {Douglas A} and Jacek Gronwald and Culver, {Hoda Anton} and Whittemore, {Alice S} and Karlan, {Beth Y} and Diether Lambrechts and Nicolas Wentzensen and Jolanta Kupryjanczyk and Jenny Chang-Claude and Bandera, {Elisa V} and Estrid Hogdall and Florian Heitz and Kaye, {Stanley B} and Fasching, {Peter A} and Ian Campbell and Goodman, {Marc T} and Tanja Pejovic and Yukie Bean and Galina Lurie and Diana Eccles and Alexander Hein and Beckmann, {Matthias W} and Ekici, {Arif B} and James Paul and Brown, {Robert James (Jim)} and Flanagan, {James M} and Philipp Harter and {du Bois}, Andreas and Ira Schwaab and Hogdall, {Claus K} and Lene Lundvall and Olson, {Sara H} and Irene Orlow and Paddock, {Lisa E} and Anja Rudolph and Ursula Eilber and Allan Jensen and {for AOCS/ACS group;}",

year = "2013",

month = may,

doi = "10.1158/1055-9965.EPI-13-0028",

language = "English",

volume = "22",

pages = "987--92",

journal = "Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",

issn = "1055-9965",

publisher = "American Association for Cancer Research Inc.",

number = "5",

}

TY - JOUR

T1 - Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

AU - White, Kristin L

AU - Vierkant, Robert A

AU - Fogarty, Zachary C

AU - Charbonneau, Bridget

AU - Block, Matthew S

AU - Pharoah, Paul D P

AU - Chenevix-Trench, Georgia

AU - Rossing, Mary Anne

AU - Cramer, Daniel W

AU - Pearce, Celeste Leigh

AU - Schildkraut, Joellen M

AU - Menon, Usha

AU - Kjaer, Susanne Kruger

AU - Levine, Douglas A

AU - Gronwald, Jacek

AU - Culver, Hoda Anton

AU - Whittemore, Alice S

AU - Karlan, Beth Y

AU - Lambrechts, Diether

AU - Wentzensen, Nicolas

AU - Kupryjanczyk, Jolanta

AU - Chang-Claude, Jenny

AU - Bandera, Elisa V

AU - Hogdall, Estrid

AU - Heitz, Florian

AU - Kaye, Stanley B

AU - Fasching, Peter A

AU - Campbell, Ian

AU - Goodman, Marc T

AU - Pejovic, Tanja

AU - Bean, Yukie

AU - Lurie, Galina

AU - Eccles, Diana

AU - Hein, Alexander

AU - Beckmann, Matthias W

AU - Ekici, Arif B

AU - Paul, James

AU - Brown, Robert James (Jim)

AU - Flanagan, James M

AU - Harter, Philipp

AU - du Bois, Andreas

AU - Schwaab, Ira

AU - Hogdall, Claus K

AU - Lundvall, Lene

AU - Olson, Sara H

AU - Orlow, Irene

AU - Paddock, Lisa E

AU - Rudolph, Anja

AU - Eilber, Ursula

AU - Jensen, Allan

AU - for AOCS/ACS group;

PY - 2013/5

Y1 - 2013/5

N2 - Ovarian cancer is a leading cause of cancer-related death among women. In an effort to understand contributors to disease outcome, we evaluated single-nucleotide polymorphisms (SNP) previously associated with ovarian cancer recurrence or survival, specifically in angiogenesis, inflammation, mitosis, and drug disposition genes.

AB - Ovarian cancer is a leading cause of cancer-related death among women. In an effort to understand contributors to disease outcome, we evaluated single-nucleotide polymorphisms (SNP) previously associated with ovarian cancer recurrence or survival, specifically in angiogenesis, inflammation, mitosis, and drug disposition genes.

KW - Female

KW - Genetic Association Studies

KW - Genetic Predisposition to Disease

KW - Genotype

KW - Humans

KW - Ovarian Neoplasms

KW - Polymorphism, Genetic

KW - Polymorphism, Single Nucleotide

KW - Prognosis

KW - Proportional Hazards Models

KW - Survival Analysis

U2 - 10.1158/1055-9965.EPI-13-0028

DO - 10.1158/1055-9965.EPI-13-0028

M3 - Journal article

C2 - 23513043

SN - 1055-9965

VL - 22

SP - 987

EP - 992

JO - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

JF - Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

IS - 5

ER -

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater